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In a previous issue of Critical Care, researchers have
focused on the venous-to-arterial carbon dioxide
difference (Pv-aCO2) as a surrogate marker for systemic
perfusion in patients with septic shock. Although the
complex mechanisms responsible for an increased
Pv-aCO2 in septic shock need to be further unraveled,
the potential prognostic value of Pv-aCO2 seems
clinically relevant and useful in daily practice in view
of its easy availability.patients with low Pv-aCO2 throughout the observationalThe resuscitation of patients with sepsis remains a chal-
lenging task. In the presence of shock, early optimization
of global and regional perfusion mandates adequate moni-
toring. Whatever kind of monitoring is used, it should
provide reliable information with potential therapeutic
and prognostic relevance. In a previous issue of Critical
Care, Ospina-Tascón and colleagues [1] describe a poten-
tially useful tool as a target for resuscitating early septic
shock. The Surviving Sepsis Campaign guidelines for early
hemodynamic optimization recommend normalization of
central venous oxygen saturation (ScvO2) [2]. ScvO2 re-
flects the imbalance between oxygen delivery (DO2) and
oxygen demand (VO2). However, in the majority of pa-
tients with severe sepsis or septic shock who are acutely
admitted to the ICU, ScvO2 values are normal or elevated
(>70%) [3]. Hence, an additional circulatory parameter is
needed to evaluate resuscitation efforts.
Ospina-Tascón and colleagues [1] have focused on the
venous-to-arterial carbon dioxide difference (Pv-aCO2) as
a surrogate marker for systemic perfusion in patients with
septic shock. This could make sense. Indeed, Pv-aCO2
may be used to mathematically calculate cardiac index [4].* Correspondence: p.van.beest@umcg.nl
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be used to discriminate between high and low lactate
clearance and cardiac index in critically ill patients who
were seemingly resuscitated [5].
In a prospective observational study, Ospina-Tascón and
colleagues [1] classify their patient population into four
predefined groups based on the evolution of Pv-aCO2 dur-
ing the first 6 hours of resuscitation. A Pv-aCO2 of at least
6 mm Hg was considered high (H), and a Pv-aCO2 of less
than 6 mm Hg was considered normal or low (L). Their
results show that two groups have better outcome: that is,
period (LL) and patients in whom Pv-aCO2 decreased
from high to low values (HL) [1]. The patients in the first
group were either less severely ill or already adequately
volume-resuscitated before ICU admission. Analogously
to earlier findings [5], the HL patients may be considered
responders to treatment mirrored by the significant lactate
clearance from 2.7 to 1.3 mmol/L. In contrast, persistently
high Pv-aCO2 values (HH) or increasing Pv-aCO2 values
(LH) predicted worse outcome. The patients in the HH
group were too severely ill, and during treatment for the
patients in the LH group a substantial oxygen debt was
probably recognized too late. In addition, an increased
mortality risk was observed when patients reached an
ScvO2 of at least 70 % with concomitantly high Pv-aCO2
values. This is in line with recent findings that Pv-aCO2
may be used as triage tool when ScvO2 values are more
than 70% on ICU admission [5,6]. Hence, Pv-aCO2 may
potentially be of prognostic value. In addition, Pv-aCO2
values can be easily obtained with low costs, making this
parameter potentially clinically relevant and useful in daily
practice.
Nevertheless, one has to bear in mind that the mecha-
nisms responsible for an increased Pv-aCO2 in patients
with septic shock are not fully understood yet. On the
microcirculatory level, distributive changes may be inde-
pendent of cardiac output (CO) [7]. This means that on
a regional level, in accordance with the possibility of
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mulation of carbon dioxide (CO2) occurs in microcircula-
tory weak units, despite adequate CO. However, Pv-aCO2
reflects the ability to wash out the accumulated CO2 bet-
ter than the presence of anaerobic metabolism [7,8]. Also,
an increased Pv-aCO2-to-VO2 ratio could reflect global
anaerobic metabolism [9], and the ratio of Pv-aCO2 di-
vided by arteriovenous oxygen content difference predicts
an increase of oxygen utilization after a fluid-induced in-
crease in DO2 [10]. This means that Pv-aCO2 values may
also be of therapeutic relevance. A decrease of heterogen-
eity of the microcirculation may potentially result in an in-
creased CO2 washout and a decreased Pv-aCO2-to-VO2
ratio. Also, the balance between DO2 and VO2 may be re-
stored. It is tempting to hypothesize that the necessary im-
proved recruitment of microcirculation in the early
resuscitation phase may be achieved by the use of vasodi-
latators in addition to volume loading [11,12]. Indeed, the
results of Ospina-Tascón and colleagues may provide an
argument to implement vasodilators within 6 hours,
which probably could be stopped after recruitment has oc-
curred. Such a strategy may be particularly beneficial to
septic shock patients resembling the patients described in
the LH group.
In conclusion, Pv-aCO2 provides us with additional in-
formation to hemodynamic and oxygen-derived parame-
ters currently used in the resuscitation of patients with
sepsis. Pv-aCO2 values seem clinically relevant and are
potentially of prognostic value.
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